Category Archives: Parkinson’s Treatment

Scientists found a way to create neurons and cure Parkinson's disease in mice, for the first time. Continue reading →

Central nervous system gene therapies and advanced technologies to provide these treatments were noted as emerging opportunities in treatment for neurological conditions such as Parkinson disease, according to review findings. Continue reading →

Stay-at-home orders and safety concerns kept many people from seeking medical treatment during the past few months. Doctors voice particular concern for those with cardiac disease Continue reading →

The National Institute on Aging has awarded a $15 million grant to the Stanford Alzheimers Disease Research Center. The award is a five-year renewal of a $7.3 million grant the institute provided to the center in 2015. Continue reading →

(MENAFN - BrandEssence Market Research Company) The Parkinson's Disease Treatment Market research report delivers a comprehensive analysis on the newest market drivers. The report also offers extracts regarding statistics, market valuation and revenue estimates, which further strengthens its status in the competitive spectrum and growth trends embraced by leading manufacturers in the business. Parkinson's disease is a neuro degenerative disorder in which parts of the brain become progressively damaged over many years. Continue reading →

Erisyon, a biotechnology company specializing in the study of proteins, was awarded agrant byThe Michael J. Fox Foundation (MJFF) to find and validate potential markers ofParkinsons diseasein its early stages Continue reading →

An innovative use of focused ultrasound being pioneered at theUniversity of Virginia School of Medicineis showing promise against glioblastoma, the deadliest brain tumor, and could prove useful against other difficult-to-treat cancers. The technique hits cancer cells with a drug that sensitizes them to sound waves, then blasts them with focused ultrasound. The sound waves create tiny bubbles inside the cancer cells, causing them to die Continue reading →

His findings spurred the establishment of human brain tissue banks, research into dopamine, and treatments of other diseases caused by low levels of neurotransmitters. Today, it is generally agreed that the initiation of the treatment of Parkinsons disease with L-dopa represented one of the triumphs of pharmacology of our time, Professor Hornykiewicz wrote in The History of Neuroscience in Autobiography, Volume IV (2004). Continue reading →

Newly developed MRI techniques can help neuroradiologists more effectively target and treat the area of the brain responsible for tremors in patients living with Parkinsons disease, leading to better surgery outcomes and fewer side effects. A research team, led by investigators from the University of Texas Southwestern (UTSW), has detailed three refined MRI methods neuroradiologists can use to precisely pinpoint the pea-sized region in the brains thalamus -- the ventral intermediate nucleas -- that is involved in movement. Providers use those MRI images with high-intensity focused ultrasound (HIFU) to burn away tissue causing movement problems Continue reading →

DALLAS June 14, 2020 Recently developed MRI techniques used to more precisely target a small area in the brain linked to Parkinsons disease and essential tremor may lead to better outcomes without surgery and with less risk of negative effects, a new study led by UT Southwestern researchers suggests. The study, published today in Brain, describes recently refined MRI methods designed to allow neuroradiologists to zero in on a pea-sized region in the brains thalamus involved in movement. Continue reading →